EXPRESSION AND SECRETION OF preS CONTAINING HEPATITIS B SURFACE ANTIGEN IN VACCINIA VIRUS SYSTEM

The expression and secretion of preS containing hepatitis B surface antigen in vaccinia virus system was investigated. The human TK~- 143 cells were infected with the recombinant vaccinia viruses vTMS-1 or vTLS-1. Cells infected with vTMS-1, which contains the preS2+S gene, produced preS2 containing middle HBsAg proteins. Similarly, cells produced preS1 containing large HBsAg proteins upon infection with vTLS-1, which carries the preS1+preS2+S gene. The expression products could be secreted and form 22 nm particles. They reacted specifically with anti-preS1 and/or anti-preS2 monoclonal antibodies, and exhibited pHSA-receptor (for polymerized human serum albumin) activity. In addition, the major S components of hepatitis B surface antigen were also present in the products expressed by vTMS-1 and vTLS-1.     

CLONING AND RESTRICTION MAPPING OF HUMAN HBV GENOME SEROTYPE adr

A Bam HI cleaved 3.2 Kb fragment from the HBV adr genome was cloned in E. coli, using pBR322 as vector. sixteen restriction sites from the action of Bam HI, Hind Ⅲ, Bgl Ⅰ, Bgl Ⅱ, Ava Ⅰ, Hinc Ⅱ, Sph Ⅰ, Xba Ⅰ, Xho Ⅰ and Sst Ⅱ were determined and mapped. No cleavage sites were found for Eco RI, Pst Ⅰ, Sma Ⅰ, Hpa Ⅰ, Kpn Ⅰ, Pvu Ⅱ and Sst Ⅰ.The restriction map for HBV adr is significantly different from those reported for the subtypes adw, ayw and adyw.     

A CLONE OF HEPATITIS B VIRUS (SUBTYPE adr) DNA WITH A NEW HINDIII SITE

We have cloned the HBV genome subtype adr through its HindⅢ site into plasmid pBR.322. Twelve recombinant plasmids each with an insert of the HBV genome were obtained. The restriction map of one of the recombinants, plasmid pADR-H1, was analyzed. The location of the sites for BamHⅠ, BglⅠ, BglⅡ, SstⅡ, XbaⅠ and XhoⅠ in pADR-HⅠ were found to be the same as that in pADR-1, but the HindⅢ site of pADR-H1 is distinctly different from that of pADR-1. The BamHⅠ-HindⅢ fragment is 316 bp long in the gcnome of pADR-1. However, it is only 82 bp in pADR-Hl. No deletion of sequence between BamHⅠ and HindⅢ sites has been found in the HBV genome of pADR-H1, The sequencing data around the HindⅢ site of pADR-H1 in both pADR-H1 and pADR-1 show that there is a stretch of AAGTTT in pADR-1 compared to an AAGCTT in pADR-H1. In addition, other differences were found. There are three sites for AvaⅠ, four for HincⅡ, one for HpaⅠ and none for SphⅠ in the genome of pADR-H1 compared to four sites for AvaⅠ, three f     

一个带有新的Hind Ⅲ切点的HBVadr基因组克隆株

本文报道利用HBVadr DNA的Hind Ⅲ切点,将HBV DNA切开,插进pBR322的Hind Ⅲ位点,获得12株带HBVadr基因组的克隆株。限制性酶切分析,发现pADR-H1虽然也只有一个Hind Ⅲ切点,但它在基因组中的位置与pADR-1不同。pADR-1的HBV DNA中,其Hind Ⅲ-Bam HI片段的大小为315 bp,而pADR-H1中的相应片段只有82bp。序列分析表明,前者82 bp处的一段AAGTTT结构,在pADR-H1中变为AAGCTT而成了Hind Ⅲ识别位点。此外,限制性内切酶AvaⅠ,HincⅡ,HpaⅠ和SphⅠ对二克隆株的作用情况也有差别。本文探讨了这些差别的意义。     

带有乙型肝炎表面抗原基因的重组痘苗病毒——一种可能的乙型肝炎活疫苗

我们组建了带有痘苗病毒胸腺嘧啶核苷激酶(TK)基因的痘苗病毒载体,并将乙型肝炎(以下简称乙肝)表面抗原(HBsAg)基因(adr亚型)插入载体质粒,置于痘苗病毒早期启动基因的调控下。通过感染与转染相结合的方法,得到了带有乙型肝炎表面抗原基因的重组痘苗病毒。它保持了原有的感染性,并能有效地表达乙肝表面抗原。当病毒接种量为每个细胞1PFU(空斑形成单位)时,每1×10~6细胞感染后24h可产生2—3μg HBsAg,其中大部分释放于细胞培养液中。每升培养液可以产生0.5—1mg HBsAg。表达产物HBsAg能形成颗粒,其大小、浮力密度,多肽组份等都与病人血清中的HBsAg颗粒相同。用重组痘苗病毒免疫家兔,可以产生抗乙肝表面抗原的专一性抗体。实验结果表明,利用本文组建的重组痘苗病毒不仅可以提供一个生产乙肝表面抗原的系统,而且这种重组痘苗病毒就可作为活疫苗使用,来预防乙肝病毒感染。     

人乙型肝炎病毒——HBVadr亚型基因组的克隆和限制酶切图谱

以pBR322为运载体将HBV adr亚型基因组Bam HI酶切的3.2Kb片段克隆入E.coli.Bam HI,HindⅢ,BglⅠ,BglⅡ,AvaⅠ,HincⅡ,SphⅠ,XbaⅠ,XhoⅠ,SstⅡ等10种限制酶的16个切点已被定位。制作了HBV adr亚型基因组的限制酶图谱。Eco RⅠ,PstⅠ,SmaⅠ,HpaⅠ,KpnⅠ,PvuⅡ,SstⅠ等没有切点,与已报道的adw,ayw,adyw亚型基因组的限制酶图谱明显不同。     

乙型肝炎病毒表面抗原preS基因在痘苗病毒系统中的分泌型表达

本文对带preS2的乙肝病毒表面抗原基因以及带preS1和preS2的乙肝表面抗原全基因的重组痘苗病毒vTMS-1和vTLS-1的表达和分泌进行了研究。在人TK-143细胞中它们能表达各自所编码的蛋白——乙肝表面抗原中分子蛋白和大分子蛋白。产物是可分泌的,并能形成22nm颗粒。分泌在培液中的表达产物能分别与抗preS2和抗preS1的单抗反应,并保持了天然表面抗原大分子和中分子蛋白所具有的多聚人血清白蛋白的受体活力。它们的表达产物中都还合有乙肝表面抗原主蛋白的成分。